Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Megan Rauscher"'
Autor:
Peter Lambert, Michelle P McIntosh, Mariana Widmer, Lawrence Evans, Megan Rauscher, Rutendo Kuwana, Fiona Theunissen, Beth Yeager, Helen Petach
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 13, Iss 1 (2020)
Background The use of quality injectable oxytocin effectively prevents and treats postpartum hemorrhage, the leading cause of maternal death worldwide. In low- and middle-income countries (LMICs), characteristics of oxytocin—specifically its heat s
Externí odkaz:
https://doaj.org/article/49ba8ab8a4774db29209f72823b5f5cc
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 10, Iss 1 (2017)
Background Medicines use related challenges such as inadequate adherence, high levels of antimicrobial resistance and preventable adverse drug reactions have underscored the need to incorporate pharmaceutical services to help achieve desired treatmen
Externí odkaz:
https://doaj.org/article/a1a7d334bd3947d09a5b97f63caf2cc7
Autor:
Megan Rauscher, Rutendo Kuwana, Lawrence Evans, Peter Lambert, Fiona Theunissen, Michelle P. McIntosh, Mariana Widmer, Helen H. Petach, Beth Yeager
Publikováno v:
Journal of Pharmaceutical Policy and Practice
Journal of Pharmaceutical Policy and Practice, Vol 13, Iss 1, Pp 1-13 (2020)
Journal of Pharmaceutical Policy and Practice, Vol 13, Iss 1, Pp 1-13 (2020)
Background The use of quality injectable oxytocin effectively prevents and treats postpartum hemorrhage, the leading cause of maternal death worldwide. In low- and middle-income countries (LMICs), characteristics of oxytocin—specifically its heat s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f3ae2cd86619e08a170729a8ac14e1c
http://europepmc.org/articles/PMC7227300
http://europepmc.org/articles/PMC7227300
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 10, Iss 1, Pp 1-13 (2017)
Journal of Pharmaceutical Policy and Practice
Journal of Pharmaceutical Policy and Practice
Background Medicines use related challenges such as inadequate adherence, high levels of antimicrobial resistance and preventable adverse drug reactions have underscored the need to incorporate pharmaceutical services to help achieve desired treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::459ef145cb540997e6bcab8bfcc4ab2b
http://link.springer.com/article/10.1186/s40545-017-0104-z
http://link.springer.com/article/10.1186/s40545-017-0104-z